Do you want to read an article? Please log in or register.
Peripartum cardiomyopathy
Cardiovascular Risk and Diseases
Related content
ESC 2025
Cardiovascular Risk and Diseases
Mavacamten monotherapy demonstrates sustained clinical benefits in obstructive hypertrophic cardiomyopathy
Atrial Fibrillation
Cardiomyopathy-Associated Gene Variants in Atrial Fibrillation
JAMA Cardiol
Wijdeveld LFJM, Ajufo E, Challa SP, Rämö JT, Wang X, Kany S, Halford JL, Weng LC, Choi SH, Aragam KG, van Tintelen JP, Brundel BJJM, Jurgens SJ, Ellinor PT
doi: 10.1001/jamacardio.2025.0460
Heart, Artery and Coronary Diseases
Aficamten or Metoprolol Monotherapy for Obstructive Hypertrophic Cardiomyopathy
N Engl J Med
Garcia-Pavia P, Maron MS, Masri A, Merkely B, Nassif ME, Peña-Peña ML, Barriales-Villa R, Bilen O, Burroughs M, Claggett B, Costabel JP, Correia EB, Dybro AM, Elliott P, Hegde SM, Lakdawala NK, Lewis GD, Mann A, Miao ZM, Nair A, Poulsen SH, Reant P, Schulze PC, Solomon SD, Wang A, Sohn R, Berhane I, Heitner SB, Jacoby DL, Kupfer S, Malik FI, Wohltman A, Fifer MA, MAPLE-HCM Investigators
doi: 10.1056/NEJMoa2504654
Further Publications
Location of LMNA Variants and Clinical Outcomes in Cardiomyopathy
JAMA Cardiol
Bhaskaran A, Ben Yaou R, Helms AS, Fayssoil A, Richard P, Stojkovic T, Anselme F, Labombarda F, Chikhaoui C, De Sandre-Giovannoli A, Jeru I, Leturcq F, Vigouroux C, Dembele M, Elliott P, Savvatis K, Zeppenfeld K, Bouguerra H, Charron P, Kumar S, Bonne G, Wahbi K, Lakdawala NK
doi: 10.1001/jamacardio.2025.2069
RECOMMENDED
Hypertension
Hypertensive Disorders of Pregnancy and Long-Term Risk of Dilated Cardiomyopathy
★ 2
Recommended by
Prof. Dr Isabella Sudano, Faculty Member
JAMA Cardiol
Tayal U, Kallis C, Massen GM, Rossberg N, Graul EL, Quint JK
doi: 10.1001/jamacardio.2025.0328
Heart, Artery and Coronary Diseases
Physical Activity and Cardiovascular Outcomes in Phenotype-Negative Cardiomyopathy Variant Carriers
JAMA Cardiol
Ajufo E, Kany S, Jurgens SJ, Churchill TW, Guseh JS, Aragam KG, Nauffal V, Pirruccello JP, Choi SH, Lakdawala NK, Ho CY, Ellinor PT, Khurshid S
doi: 10.1001/jamacardio.2025.4466
Heart Failure
Early genetic screening and cardiac intervention in patients with cardiomyopathies in a multidisciplinary clinic
ESC Heart Fail
Sadasivan C, Gagnon LR, Hazra D, Wang K, Youngson E, Thomas J, Chan AYM, Paterson DI, McAlister FA, Dzwiniel T, Tymchak W, Christian S, Oudit GY
doi: 10.1002/ehf2.15202
Cardiac Arrest or Death
Global and Temporal Trends in Utilization and Outcomes of Implantable Cardioverter Defibrillators in Hypertrophic Cardiomyopathy
Circ Arrhythm Electrophysiol
Abdelfattah OM, Sayed A, Al-Jwaid A, Hassan A, Abu Jazar D, Narayanan A, Link MS, Martinez MW
doi: 10.1161/CIRCEP.124.013479
Further Publications
Accelerometry-defined physical activity and quality of life in hypertrophic cardiomyopathy
Heart
Schoonvelde SAC, Zwetsloot PP, Hirsch A, Schinkel AFL, Knackstedt C, Germans T, van Slegtenhorst MA, Verhagen JMA, de Boer RA, Michels M
doi: 10.1136/heartjnl-2025-326217